companydata.dkcompanydata.dk

VIPERGEN R & D III K/S: Financial statements 2014

CVR: 30355644

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 805,000 and a net result of DKK -12,291,000 compared with DKK -10,661,000 the year before. That is an increase of 0.1% compared with the year before. The profit margin was -1,526.8%. Equity in the 2014 report amounted to DKK 932,000. The solvency ratio was 23%.

Revenue
DKK 805,000
Profit/Loss
DKK -12,291,000
Equity
DKK 932,000
Total Assets
DKK 4,047,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014805K--12.3M932K-
2013804K--10.7M-1.8M-
20120--10.2M8.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

VIPERGEN R & D III K/S: The 2013 annual report is outJun 4, 2014

VIPERGEN R & D III K/S has published its annual report for 2013. Revenue came to DKK 804,000, and the net result was DKK -10,661,000.

About VIPERGEN R & D III K/S

VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.

Source: annual report 2018, Danish Business Authority

Other financial years